New drug combo aims to control bladder cancer when standard therapy fails
Disease control
Recruiting now
This study tests two drugs, durvalumab and monalizumab, given together to people with a type of bladder cancer that has not gotten better with standard treatment. The goal is to see if the combination can make the cancer disappear or stop it from growing. About 60 adults will tak…
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC